Controversial Harvard psychiatrist Joseph Biederman has agreed to stop working on clinical trials funded by industry until Massachusetts General Hospital finishes looking into allegations that he didn’t adequately report the funding he has received from drugmakers. Sen. Charles Grassley (R., Iowa) has accused Biederman of failing to disclose more than $1.6 million in payments he received from companies including Johnson & Johnson and Eli Lilly. Biederman is also taking fire over a research ins

Eli Lilly , Johnson & Johnson and other drugmakers misled consumers about medicines to treat attention deficit disorder in various sales pitches, US regulators said in letters released on Friday.

Eli Lilly , Johnson & Johnson and other drugmakers misled consumers about medicines to treat attention deficit disorder in various sales pitches, US regulators said in letters released on Friday.

Despite huge marketing and PR blunders for some pharmaceutical companies over the past few years (most notably Eli Lilly’s Laurel and Hardy cover-up of Zyprexa’s negative side effects), some of these companies seem to be having difficulty learning from past mistakes. Bad economy? Empty drug pipeline? I don’t know what the excuse is for their sales and marketing folks to not police their own advertisements, but the U.S. Food and Drug Administration noticed the infractions and sent letters to eac

Despite huge marketing and PR blunders for some pharmaceutical companies over the past few years (most notably Eli Lilly’s Laurel and Hardy cover-up of Zyprexa’s negative side effects), some of these companies seem to be having difficulty learning from past mistakes. Bad economy? Empty drug pipeline? I don’t know what the excuse is for their sales and marketing folks to not police their own advertisements, but the U.S. Food and Drug Administration noticed the infractions and sent letters to eac